What is it about?
This comprehensive review analyzes the phytochemistry and biological activities of over 600 species from the genus Galium (family Rubiaceae)—commonly known as bedstraws—by synthesizing literature published between 1995 and 2024 across major databases such as ScienceDirect, Scopus, Embase, and Medline. Highlighting key species such as Galium verum, Galium aparine, Galium mollugo, and Galium odoratum, the study links their traditional medicinal uses across the Americas, Europe, and Asia to a diverse array of isolated bioactive metabolites, including phenolic compounds, iridoid glycosides, anthraquinones, phytosterols, saponins, and essential oils. The findings demonstrate that these constituents impart significant antimicrobial, antioxidant, anti-cancer, immunomodulatory, and anti-inflammatory effects, thereby providing a consolidated pharmacological foundation to stimulate future drug discovery and isolate novel therapeutic lead compounds from the genus worldwide.
Featured Image
Photo by Wenzy Wong on Unsplash
Why is it important?
This study is important because it consolidates three decades (1995–2024) of scattered phytochemical and pharmacological research on the globally distributed genus Galium (bedstraws), validating its extensive traditional medicinal uses with modern scientific evidence. By mapping the diverse structural classes of bioactive metabolites—such as iridoid glycosides, anthraquinones, and phenolics—to specific therapeutic effects including anti-cancer, antimicrobial, immunomodulatory, and anti-inflammatory activities, the study establishes a critical foundation for researchers to target unexplored species and accelerate the discovery and development of novel plant-derived therapeutic agents.
Perspectives
The perspective of this study approaches the genus Galium through an ethnopharmacological and natural-product drug discovery lens, viewing traditional bedstraw remedies as structurally diverse chemical libraries rather than mere folk medicine. By systematically correlating nearly thirty years of literature on isolated plant metabolites—such as iridoid glycosides, phenolics, and anthraquinones—with validated biological mechanisms (including anti-cancer, immunomodulatory, and antimicrobial effects), the authors adopt a forward-looking perspective that positions traditional botanical knowledge as an essential pathway for identifying novel lead compounds and driving modern pharmaceutical research.
Dr Mayssaloune Ali Kanso
Beirut Arab University
Read the Original
This page is a summary of: Review on phytochemical constituents and pharmacological activities of genus Galium, Journal of Applied Pharmaceutical Science, September 2024, SAGE Publications,
DOI: 10.7324/japs.2024.195572.
You can read the full text:
Contributors
The following have contributed to this page
